Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.
about
Long non-coding RNAs in nervous system function and diseaseBarth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell StudiesLeber hereditary optic neuropathy: current perspectivesNew opportunities: harnessing induced pluripotency for discovery in diabetes and metabolismMigraine headache: a review of the molecular genetics of a common disorderClinico-radiological spectrum of bilateral temporal lobe hyperintensity: a retrospective reviewGenetic Risk Factors for Ischemic and Hemorrhagic StrokeImpact of the mitochondrial genetic background in complex III deficiencyAddressing RNA integrity to determine the impact of mitochondrial DNA mutations on brain mitochondrial function with age.Total intravenous anesthesia with propofol and remifentanil in a patient with MELAS syndrome -A case report-Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.Leukoencephalopathies in mitochondrial disorders: clinical and MRI findings.Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes.Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndromeThe neuro-ophthalmology of mitochondrial diseaseThe effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome.Glucose metabolism derangements in adults with the MELAS m.3243A>G mutationMitochondrial DNA variant m.15218A > G in Finnish epilepsy patients who have maternal relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus.Mitochondrial encephalopathy, lactic acidosis, and stroke-like episode syndrome presenting with prolonged visual aura.Speech-Language and swallowing manifestations and rehabilitation in an 11-year-old girl with MELAS syndromeWolff-Parkinson-white syndrome in a patient with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes syndromeL-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII.Mitochondrial genetic analysis in a Chinese family suffering from both mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes and diabetesMetabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp).Embryonic Lethality of Mitochondrial Pyruvate Carrier 1 Deficient Mouse Can Be Rescued by a Ketogenic Diet.Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the diseaseReduced mitochondrial Ca(2+) transients stimulate autophagy in human fibroblasts carrying the 13514A>G mutation of the ND5 subunit of NADH dehydrogenase.OXPHOS mutations and neurodegenerationImpaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.Genetic counseling in mitochondrial disease.Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseasesA case of mitochondrial cardiomyopathy with restrictive transmitral filling patternThe emerging role of epigenetics in stroke: II. RNA regulatory circuitry.Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke.Mitochondrial retrograde signaling in the Drosophila nervous system and beyond.Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination.A diagnostic algorithm for metabolic myopathies
P2860
Q24595656-9E1BE137-AD7A-42CE-A6BB-454BAF48B6C6Q26772690-ED60098C-1FE2-4575-88E4-E7D575E7A88DQ26863599-85B21D95-ED4D-4063-9440-009BBFA4EE3EQ26995562-A9B0314C-E0BA-4F64-9E7A-9AA0C411C788Q27010458-105A75C6-F4F3-4E2D-9187-AD26612DB684Q27013636-8C02445F-45C4-4A89-8344-2B9EA1B77F6DQ28079249-2C7407BB-5C81-4A6E-B55A-34C789C4EC6BQ28475526-378A3FD3-6BC7-4ADE-BC35-E189CD4F624DQ31161078-B71152DF-B190-4B76-A93E-673A480ADEACQ33878198-E714B172-47BC-4E50-9B07-D39A94AD2C73Q33887449-1DAEBB49-C8F1-402C-90B5-3E916D86BAF3Q34150287-540A9791-DF95-4A50-838A-A280AE61021CQ34162244-8E3F1363-63B2-4EB8-9C8C-D33670C155E6Q34165551-040D75A8-2C90-4E0D-9F27-2C9AF56E5C91Q34338783-651F5890-BC3B-41DF-B251-65C2A176F55AQ34380418-6632C680-E96D-4697-98DF-C53955A7F4D3Q34615869-4738AE04-F1EE-4C52-A7E8-FC5435F5F621Q34839861-F8C1EA72-31B6-4679-9FCC-2B7154C303FAQ34996511-632B30C0-0323-428B-98D5-58FEFD94F7EFQ35401186-AFA4A9D3-D550-468C-B295-C3C607AAF5ABQ35622101-E8067B0B-CE6D-4ADF-ACEC-B90615554C02Q35628861-CEFF2240-5F0A-4079-83AF-FA0EB47DE8EAQ35657769-0CF1C0C9-6BF9-4A8A-B63F-CF195A8EEB4EQ35919258-6F77B899-20B8-4DC5-8BE9-38EBCE8E4C98Q35919630-B3CDF00F-5059-4C1D-8218-60D2C40D7C25Q35987033-1057A050-2D34-4F73-A524-5BE462ACBF07Q36017259-C60A983E-555F-4E5C-BEA4-01386A238388Q36419316-C58619AC-1B91-4AD4-A053-69E5260DE729Q36472468-C872D68D-2360-4E32-9B72-8AE0C83F3666Q36533623-3B51195E-1F0D-4DAF-8D2C-EDB860B5672BQ36759443-40D37485-3C4E-4587-8397-CF29ED1FF767Q36762834-0F2A82CC-0700-49A2-8C55-F6DCB2CB9D97Q36771650-4B983E84-F362-4640-98EA-AF6E83185829Q36856622-8B48E2F0-77E2-4A79-8350-9008B0232EA6Q36886962-9F60B588-2ECD-42B7-9B87-AC735DBC6CE1Q36961798-3F879851-0C19-40AC-96B9-4F5E91EAE3DDQ37069762-60C684B9-C302-4381-AC65-9C37C716D8DAQ37210464-17333348-0413-43A9-9A80-C9B4600E9890Q37561288-58675256-E238-4688-B193-6204AF238E29Q37738321-5F300800-4536-404F-B90B-219B14567239
P2860
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@en
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@nl
type
label
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@en
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@nl
prefLabel
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@en
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@nl
P2860
P356
P1476
Mitochondrial encephalopathy, ...... management of MELAS syndrome.
@en
P2093
Douglas M Sproule
Petra Kaufmann
P2860
P304
P356
10.1196/ANNALS.1444.011
P407
P577
2008-10-01T00:00:00Z